Logo do repositório
 
Publicação

Corrigendum to

dc.contributor.authorSilva, Ana Teresa
dc.contributor.authorOliveira, Isabel S.
dc.contributor.authorGomes, Joana M.
dc.contributor.authorAguiar, Luísa
dc.contributor.authorFontinha, Diana
dc.contributor.authorDuarte, Denise Maria Figueiredo Araújo
dc.contributor.authorNogueira, Fátima
dc.contributor.authorPrudêncio, Miguel
dc.contributor.authorMarques, Eduardo F.
dc.contributor.authorTeixeira, Cátia A. S.
dc.contributor.authorFerraz, Ricardo
dc.contributor.authorGomes, Paula
dc.contributor.institutionVector borne diseases and pathogens (VBD)
dc.contributor.institutionGlobal Health and Tropical Medicine (GHTM)
dc.contributor.institutionInstituto de Higiene e Medicina Tropical (IHMT)
dc.contributor.pblJohn Wiley & Sons, Ltd.
dc.date.accessioned2023-06-16T22:19:44Z
dc.date.available2023-06-16T22:19:44Z
dc.date.issued2023-01-03
dc.description.abstractScheme 1 and Figure 1 in this article were incorrect. The correct ones, and their respective captions, follow: 1 Scheme (Figure presented.) Synthesis route to PQ-derived organic salts 3a–g. (i) 1a (1 molar equivalent, eq), 2a–g (1 eq), methanol (MeOH), room temperature (RT), 30 min. 1 Figure (Figure presented.) Surface tension plots and cmc determination, at 25 °C, of aqueous CTAB/SAIL mixtures: A) surface tension vs. the logarithm of total CTAB+SAIL concentration, expressed in molality; the cmc values are obtained from the intersection points of the linear fit in each system; B) cmc vs. molar fraction of 3c in mixtures with CTAB, showing the marked effect of 3c in reducing cmc.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent417435
dc.identifier.doi10.1002/cmdc.202200589
dc.identifier.issn1860-7179
dc.identifier.otherPURE: 61130870
dc.identifier.otherPURE UUID: 85469fdd-b032-42cc-baea-e03d2a87f736
dc.identifier.otherPubMed: 36480787
dc.identifier.otherScopus: 85143608295
dc.identifier.otherWOS: 000895458900001
dc.identifier.otherORCID: /0000-0003-0313-0778/work/151409102
dc.identifier.urihttp://hdl.handle.net/10362/154056
dc.identifier.urlhttps://www.scopus.com/pages/publications/85143608295
dc.identifier.urlhttps://www.scopus.com/pages/publications/85143608295
dc.language.isoeng
dc.peerreviewedyes
dc.subjectAntimalarial
dc.subjectPlasmodium
dc.subjectSAIL
dc.subjectblood-stage
dc.subjectfatty acid
dc.subjectionic liquid
dc.subjectliver-stage
dc.subjectsurface activity
dc.subjectRM Therapeutics. Pharmacology
dc.subjectRA0421 Public health. Hygiene. Preventive Medicine
dc.subjectQR Microbiology
dc.subjectDrug Discovery
dc.subjectMolecular Medicine
dc.subjectBiochemistry
dc.subjectPharmacology, Toxicology and Pharmaceutics(all)
dc.subjectPharmacology
dc.subjectOrganic Chemistry
dc.subjectSDG 3 - Good Health and Well-being
dc.subjectSDG 9 - Industry, Innovation, and Infrastructure
dc.titleCorrigendum toen
dc.title.subtitleDrug-Derived Surface-Active Ionic Liquids: A Cost-Effective Way To Expressively Increase the Blood-Stage Antimalarial Activity of Primaquine (ChemMedChem, (2022), 17, 5, 10.1002/cmdc.202100650)en
dc.typeother
degois.publication.issue1
degois.publication.titleChemmedchem
degois.publication.volume18
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
CORRIGENDUM.pdf
Tamanho:
407.65 KB
Formato:
Adobe Portable Document Format